Interference of B lymphocyte tolerance by prolactin in rheumatic autoimmune diseases
- PMID: 37332964
- PMCID: PMC10276217
- DOI: 10.1016/j.heliyon.2023.e16977
Interference of B lymphocyte tolerance by prolactin in rheumatic autoimmune diseases
Abstract
Systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and systemic sclerosis (SSc) are the most common rheumatic autoimmune diseases/disorders (RADs) that affect autologous connective tissues as a result of the breakdown of the self-tolerance mechanisms of the immune system. Prolactin, a glycoprotein hormone, has been known for its crucial role in the pathogenesis of these rheumatic autoimmune diseases. In addition to regulating lymphocyte proliferation and antibody synthesis, prolactin is also responsible for regulating cytokine production. Moreover, it contributes to the breakdown of central and peripheral tolerance mechanisms of B lymphocytes. Given the crucial role of prolactin in the pathogenesis of the mentioned RADs, prolactin may contribute to their pathogenesis by the breakdown of tolerance. In the present study, the key role of prolactin to the breakdown of B lymphocyte tolerance and its possible implication for the pathogenesis of these diseases is discussed. Current literature supports prolactin's role in the breakdown of B lymphocyte central and peripheral tolerance mechanisms, such apoptosis, receptor editing, and also anergy. Therefore, prolactin may contribute to the pathogenesis of RADs by the breakdown of B lymphocyte tolerance. However, more investigations, particularly in RA and SSc animal models, are required to precisely address the pathologic role of prolactin.
Keywords: Autoimmune disease; B lymphocyte; B lymphocyte tolerance; Prolactin; Rheumatic autoimmune disease; Tolerance.
© 2023 The Authors.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures


Similar articles
-
[Prolactin in connective tissue diseases].Postepy Hig Med Dosw (Online). 2006;60:278-85. Postepy Hig Med Dosw (Online). 2006. PMID: 16715039 Review. Polish.
-
Calcium Signaling: From Normal B Cell Development to Tolerance Breakdown and Autoimmunity.Clin Rev Allergy Immunol. 2017 Oct;53(2):141-165. doi: 10.1007/s12016-017-8607-6. Clin Rev Allergy Immunol. 2017. PMID: 28500564 Review.
-
[Prolactin, a link between the neuroendocrine and immune systems. Role in the pathogenesis of rheumatic diseases].Rev Rhum Ed Fr. 1994 Apr;61(4):278-85. Rev Rhum Ed Fr. 1994. PMID: 7920527 Review. French.
-
Prolactin, systemic lupus erythematosus, and autoreactive B cells: lessons learnt from murine models.Clin Rev Allergy Immunol. 2011 Feb;40(1):8-15. doi: 10.1007/s12016-009-8182-6. Clin Rev Allergy Immunol. 2011. PMID: 19937157 Review.
-
[A review of the effects of prolactin hormone and cytokine on the development and pathogenesis of autoimmune diseases].Vnitr Lek. 2010 May;56(5):402-13. Vnitr Lek. 2010. PMID: 20578590 Review. Czech.
Cited by
-
Circulating prolactin levels and the effect of dopaminergic agonists in systemic lupus erythematosus: a systematic review and meta-analysis.Sci Rep. 2024 Dec 3;14(1):30143. doi: 10.1038/s41598-024-74749-y. Sci Rep. 2024. PMID: 39627209 Free PMC article.
References
-
- Clapp C., et al. Regulation of blood vessels by prolactin and vasoinhibins. Adv. Exp. Med. Biol. 2015;846:83–95. - PubMed
-
- Bewley T.A., Li C.H. Circular dichroism studies on human pituitary growth hormone and ovine pituitary lactogenic hormone. Biochemistry. 1972;11(5):884–888. - PubMed
-
- Goffin V., Martial J.A., Summers N.L. Use of a model to understand prolactin and growth hormone specificities. Protein Eng. Des. Sel. 1995;8(12):1215–1231. - PubMed
Publication types
LinkOut - more resources
Full Text Sources